SK133997A3 - Derivatives of ascomycin, method for the preparation thereof and pharmaceutical composition containing the same - Google Patents

Derivatives of ascomycin, method for the preparation thereof and pharmaceutical composition containing the same Download PDF

Info

Publication number
SK133997A3
SK133997A3 SK1339-97A SK133997A SK133997A3 SK 133997 A3 SK133997 A3 SK 133997A3 SK 133997 A SK133997 A SK 133997A SK 133997 A3 SK133997 A3 SK 133997A3
Authority
SK
Slovakia
Prior art keywords
compound
group
compound according
groups
carboxy
Prior art date
Application number
SK1339-97A
Other languages
English (en)
Slovak (sk)
Inventor
Rene Hersperger
Reto Naef
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9507128.8A external-priority patent/GB9507128D0/en
Priority claimed from GBGB9526049.3A external-priority patent/GB9526049D0/en
Priority claimed from GBGB9526050.1A external-priority patent/GB9526050D0/en
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of SK133997A3 publication Critical patent/SK133997A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/18—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/01—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing oxygen

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
SK1339-97A 1995-04-06 1996-04-04 Derivatives of ascomycin, method for the preparation thereof and pharmaceutical composition containing the same SK133997A3 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9507128.8A GB9507128D0 (en) 1995-04-06 1995-04-06 Organic compounds
GBGB9526049.3A GB9526049D0 (en) 1995-12-20 1995-12-20 Organic compounds
GBGB9526050.1A GB9526050D0 (en) 1995-12-20 1995-12-20 Organic compounds
PCT/EP1996/001492 WO1996031514A1 (en) 1995-04-06 1996-04-04 Ascomycins

Publications (1)

Publication Number Publication Date
SK133997A3 true SK133997A3 (en) 1998-05-06

Family

ID=27267660

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1339-97A SK133997A3 (en) 1995-04-06 1996-04-04 Derivatives of ascomycin, method for the preparation thereof and pharmaceutical composition containing the same

Country Status (21)

Country Link
US (1) US5925649A (xx)
EP (1) EP0819130A1 (xx)
JP (1) JP2000505044A (xx)
KR (1) KR19980703583A (xx)
CN (1) CN1088068C (xx)
AR (1) AR004480A1 (xx)
AU (1) AU703523B2 (xx)
BR (1) BR9604808A (xx)
CA (1) CA2216562A1 (xx)
CO (1) CO4750668A1 (xx)
CZ (1) CZ312397A3 (xx)
FI (1) FI973529A (xx)
HU (1) HUP9801993A3 (xx)
IL (1) IL117815A (xx)
MX (1) MX9707636A (xx)
NO (1) NO309273B1 (xx)
NZ (1) NZ307170A (xx)
PL (1) PL322553A1 (xx)
SK (1) SK133997A3 (xx)
TR (1) TR199700999T1 (xx)
WO (1) WO1996031514A1 (xx)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE464900T1 (de) 1998-03-26 2010-05-15 Astellas Pharma Inc Retardpräparat mit makroliden wie tacrolimus
GB9826656D0 (en) * 1998-12-03 1999-01-27 Novartis Ag Organic compounds
US6121257A (en) * 1999-03-31 2000-09-19 Abbott Laboratories Sulfamate containing macrocyclic immunomodulators
US7063857B1 (en) 1999-04-30 2006-06-20 Sucampo Ag Use of macrolide compounds for the treatment of dry eye
CZ20013769A3 (cs) * 1999-04-30 2002-03-13 Sucampo Ag Činidlo pro léčbu suchého oka
EP1210121A2 (en) 1999-08-24 2002-06-05 Cellgate Inc. Enhancing drug delivery across and into epithelial tissues using oligo arginine moieties
AR033151A1 (es) * 2001-04-12 2003-12-03 Sucampo Pharmaceuticals Inc Agente para el tratamiento oftalmico topico de las enfermedades inflamatorias oculares
JP2005512946A (ja) * 2001-05-09 2005-05-12 ノバルティス アクチエンゲゼルシャフト 選択的免疫調節法
US20060035879A1 (en) * 2002-11-15 2006-02-16 Prescott Margaret F Organic Compounds
EP1594484A2 (en) * 2003-02-17 2005-11-16 Cipla Ltd. Pharmaceutical patch
TWI324604B (en) * 2003-06-18 2010-05-11 Novartis Ag New use of staurosporine derivatives
US7780973B2 (en) * 2003-12-15 2010-08-24 Ethicon Endo-Surgery, Inc. Method and device for minimally invasive implantation of biomaterial
CA2552305A1 (en) * 2003-12-30 2005-07-14 Astellas Pharma Inc. Use of macrolides for treating or preventing airflow obstruction
US20050142161A1 (en) * 2003-12-30 2005-06-30 Freeman Lynetta J. Collagen matrix for soft tissue augmentation
EP1848541A4 (en) * 2005-02-07 2013-01-16 Pharmalight Inc METHOD AND DEVICE FOR OPHTHALMIC DELIVERY OF PHARMACEUTICALLY ACTIVE INGREDIENTS
EP3246036B1 (en) 2014-10-28 2021-10-13 Koushi Yamaguchi Medicine for improving pregnancy-induced hypertension syndrome
AU2019318035A1 (en) 2018-08-10 2021-03-04 Koushi Yamaguchi Therapeutic agent for humoral immunity-related diseases in materno-fetal relationship
EP3900729A4 (en) 2018-12-18 2022-09-07 Koushi Yamaguchi AGENT FOR TREATING INFERTILITY, RECURRENT MISSORAGE AND IMPROVING PREGNANCY

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3244592A (en) * 1962-06-09 1966-04-05 Arai Tadashi Ascomycin and process for its production
US4894366A (en) * 1984-12-03 1990-01-16 Fujisawa Pharmaceutical Company, Ltd. Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same
JPS6317884A (ja) * 1986-05-30 1988-01-25 Fujisawa Pharmaceut Co Ltd トリシクロ化合物
JPH01125394A (ja) * 1987-11-10 1989-05-17 Mect Corp シアロシルグリセロリピッド類及びその製造方法
DE3853477T2 (de) * 1987-12-09 1995-11-09 Fisons Plc Makrozyklische verbindungen.
EP0487593A1 (en) * 1989-08-18 1992-06-03 FISONS plc Macrocyclic compounds
KR0159766B1 (ko) * 1989-10-16 1998-12-01 후지사와 토모키치로 양모제 조성물
AU640963B2 (en) * 1989-11-09 1993-09-09 MEDA Pharma S.a.r.l Heteroatoms-containing tricyclic compounds
WO1991013899A1 (en) * 1990-03-12 1991-09-19 Fujisawa Pharmaceutical Co., Ltd. Tricyclo compounds
WO1991019495A1 (en) * 1990-06-11 1991-12-26 Fujisawa Pharmaceutical Co., Ltd. Use of a macrolide compound such as fk 506 for manufacturing a medicament for treating idiopathic thrombocytopenic purpura and basedow's disease
MY110418A (en) * 1990-07-02 1998-05-30 Novartis Ag Heteroatoms-containing tricyclic compounds.
ATE150304T1 (de) * 1990-09-04 1997-04-15 Fujisawa Pharmaceutical Co Tricyclische verbindungen enthaltende salben
CA2054983A1 (en) * 1990-11-08 1992-05-09 Sotoo Asakura Suspendible composition and process for preparing the same
US5208241A (en) * 1991-09-09 1993-05-04 Merck & Co., Inc. N-heteroaryl, n-alkylheteroaryl, n-alkenylheteroaryl and n-alkynylheteroarylmacrolides having immunosuppressive activity
US5247076A (en) * 1991-09-09 1993-09-21 Merck & Co., Inc. Imidazolidyl macrolides having immunosuppressive activity
US5252732A (en) * 1991-09-09 1993-10-12 Merck & Co., Inc. D-heteroaryl, O-alkylheteroaryl, O-alkenylheteroaryl and O-alkynylheteroarylmacrolides having immunosuppressive activity
US5457194A (en) * 1993-03-17 1995-10-10 Abbott Laboratories Substituted aliphatic amine-containing macrocyclic immunomodulators
EP0786986B1 (en) * 1994-10-26 2002-03-20 Novartis AG Use of an unsaturated fatty alcohol

Also Published As

Publication number Publication date
BR9604808A (pt) 1998-06-09
FI973529A (fi) 1997-11-25
CA2216562A1 (en) 1996-10-10
NZ307170A (en) 1999-03-29
KR19980703583A (ko) 1998-11-05
AU703523B2 (en) 1999-03-25
CO4750668A1 (es) 1999-03-31
IL117815A (en) 2000-07-16
PL322553A1 (en) 1998-02-02
FI973529A0 (fi) 1997-08-27
NO974536L (no) 1997-10-01
WO1996031514A1 (en) 1996-10-10
NO974536D0 (no) 1997-10-01
EP0819130A1 (en) 1998-01-21
HUP9801993A2 (hu) 1998-12-28
US5925649A (en) 1999-07-20
MX9707636A (es) 1998-06-30
HUP9801993A3 (en) 2000-04-28
TR199700999T1 (xx) 1998-01-21
CN1180359A (zh) 1998-04-29
NO309273B1 (no) 2001-01-08
AU5645396A (en) 1996-10-23
IL117815A0 (en) 1996-08-04
CN1088068C (zh) 2002-07-24
JP2000505044A (ja) 2000-04-25
AR004480A1 (es) 1998-12-16
CZ312397A3 (cs) 1998-01-14

Similar Documents

Publication Publication Date Title
SK133997A3 (en) Derivatives of ascomycin, method for the preparation thereof and pharmaceutical composition containing the same
US5486523A (en) Carbamates of rapamycin
US9499849B2 (en) Processes for preparing tubulysins
US5489680A (en) Carbamates of rapamycin
US6294517B1 (en) Compositions and kits comprising alpha-adrenergic receptor antagonists and nitric oxide donors and methods of use
AU722480B2 (en) Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses
US20060247216A1 (en) Steroid compounds comprising superoxide dismutase mimic groups and nitric oxide donor groups, and their use in the preparation of medicaments
JP2002523450A (ja) ニトロソ化およびニトロシル化されたホスホジエステラーゼ阻害剤、組成物および使用方法
PL207636B1 (pl) Produkt sprzężenia związku makrolidowego specyficznego wobec komórek immunokompetentnych ze związkiem o działaniu przeciwzapalnym i jego zastosowanie
RO107656B1 (ro) Derivati de beta-carbonil-carboxiamide ale 1,3-tiazolidinelor si procedeu pentru prepararea acestora
US5266566A (en) Method of treating fungal infections using sterodial ester compounds
RU2173688C2 (ru) Аскомицины, способ их получения и фармацевтическая композиция на их основе
SK14812001A3 (sk) Maduraftalazínové deriváty a ich použitie ako inhibítorov prozápalových cytokínov
JP2003512450A (ja) 可溶性ヒトｃｄ２３形成阻害剤としてのヒドロキサム酸誘導体
JP3956188B2 (ja) プリン誘導体２水和物、それを有効成分として含む医薬およびその製造中間体
US8012993B2 (en) Stable S-nitrosothiols, method of synthesis and use
US4609657A (en) Ergot peptide alkaloid derivatives, processes for their preparation and pharmaceutical compositions containing them
JP2024063194A (ja) マクロライド化合物及びその慢性呼吸器疾患の治療用途
HU210248B (en) Process for preparing 3-l-(5-thioxo-l-prolyl)-thiazolidine-4-carboxylic acid, derivatives thereof and pharmaceutical compositions containing them
JP2014091677A (ja) キチナーゼ阻害剤
IE904627A1 (en) Methods of using 2-isopropyl-2-phenylaminovaleronitriles immunosuppressants and vasodilators
JP2016527280A (ja) ジフェニルオキシアルキルアミン誘導体およびアリールオキシアルキルアミン誘導体、薬学的組成物、慢性肺炎症性疾患を治療、予防、または阻止するための前記薬学的組成物の使用、ならびにそのような疾患を治療または予防するための方法